Literature DB >> 16687433

Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis.

S Joossens, J-F Colombel, C Landers, D Poulain, K Geboes, X Bossuyt, S Targan, P Rutgeerts, W Reinisch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16687433      PMCID： PMC1860125          DOI： 10.1136/gut.2005.089623

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  7 in total

1.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Authors:  Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

2.  Pseudomonas fluorescens encodes the Crohn's disease-associated I2 sequence and T-cell superantigen.

Authors:  Bo Wei; Tiffany Huang; Harnisha Dalwadi; Christopher L Sutton; David Bruckner; Jonathan Braun
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  Colonic bacteria express an ulcerative colitis pANCA-related protein epitope.

Authors:  O Cohavy; D Bruckner; L K Gordon; R Misra; B Wei; M E Eggena; S R Targan; J Braun
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

4.  Identification of a novel bacterial sequence associated with Crohn's disease.

Authors:  C L Sutton; J Kim; A Yamane; H Dalwadi; B Wei; C Landers; S R Targan; J Braun
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

5.  Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype.

Authors:  Ian D R Arnott; Carol J Landers; Elaine J Nimmo; Hazel E Drummond; Ben K R Smith; Stephan R Targan; Jack Satsangi
Journal:  Am J Gastroenterol       Date:  2004-12       Impact factor: 10.864

6.  Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease.

Authors:  William S Mow; Eric A Vasiliauskas; Ying-Chao Lin; Phillip R Fleshner; Konstantinos A Papadakis; Kent D Taylor; Carol J Landers; Maria T Abreu-Martin; Jerome I Rotter; Huiying Yang; Stephan R Targan
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

7.  Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens.

Authors:  Carol J Landers; Offer Cohavy; Rajeev Misra; Huiying Yang; Ying-Chao Lin; Jonathan Braun; Stephan R Targan
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682
  7 in total
  19 in total

1.  Current and future role of serogenomics in ulcerative colitis.

Authors:  Mark H Flasar; Raymond K Cross; David B Doman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-11

Review 2.  Serum anti-glycan antibody biomarkers for inflammatory bowel disease diagnosis and progression: a systematic review and meta-analysis.

Authors:  Amit Kaul; Susan Hutfless; Ling Liu; Theodore M Bayless; Michael R Marohn; Xuhang Li
Journal:  Inflamm Bowel Dis       Date:  2012-01-31       Impact factor: 5.325

Review 3.  Is indeterminate colitis determinable?

Authors:  William J Tremaine
Journal:  Curr Gastroenterol Rep       Date:  2012-04

Review 4.  New pathophysiological insights and modern treatment of IBD.

Authors:  Matthias A Engel; Markus F Neurath
Journal:  J Gastroenterol       Date:  2010-03-09       Impact factor: 7.527

Review 5.  Biomarkers in inflammatory bowel disease: current practices and recent advances.

Authors:  Heba N Iskandar; Matthew A Ciorba
Journal:  Transl Res       Date:  2012-02-01       Impact factor: 7.012

Review 6.  Clinical Utility of Biomarkers in IBD.

Authors:  Gerhard Rogler; Luc Biedermann
Journal:  Curr Gastroenterol Rep       Date:  2015-07

Review 7.  The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease.

Authors:  James D Lewis
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

Review 8.  Diagnostic and Prognostic Microbial Biomarkers in Inflammatory Bowel Diseases.

Authors:  Marla Dubinsky; Jonathan Braun
Journal:  Gastroenterology       Date:  2015-08-15       Impact factor: 22.682

9.  Multivariate modeling identifies neutrophil- and Th17-related factors as differential serum biomarkers of chronic murine colitis.

Authors:  Megan E McBee; Yu Zeng; Nicola Parry; Cathryn R Nagler; Steven R Tannenbaum; David B Schauer
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

Review 10.  Utility of serological markers in inflammatory bowel diseases: gadget or magic?

Authors:  Maria Papp; Gary L Norman; Istvan Altorjay; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.